Buy, sell, hold, page-12

Last time I doubled up and was happy to have done that, but no way in the world I would do it again. But having said that the price is pretty cheap if they get a couple of decent things happening, but my trust in management is now completely absent, they and Experien must have had a reasonable inkling that FDA was not going to approve us, hence the CR imo. I don’t think we have heard the last on that either, there would be some very rich Sophs who may want to take that further.